Cargando…

Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats

AIM: The objective of the study was to assess the effect of combination treatment of insulin, pioglitazone and synbiotic on streptozotocin (STZ)-induced diabetic rats. MATERIALS AND METHODS: Diabetes mellitus was induced chemically by intraperitoneal administration of STZ (40 mg/kg b.wt) to male Spr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavitha, K., Reddy, A. Gopala, Reddy, K. Kondal, Kumar, C. S. V. Satish, Boobalan, G., Jayakanth, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Veterinary World 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819359/
https://www.ncbi.nlm.nih.gov/pubmed/27051195
http://dx.doi.org/10.14202/vetworld.2016.118-122
_version_ 1782425184253247488
author Kavitha, K.
Reddy, A. Gopala
Reddy, K. Kondal
Kumar, C. S. V. Satish
Boobalan, G.
Jayakanth, K.
author_facet Kavitha, K.
Reddy, A. Gopala
Reddy, K. Kondal
Kumar, C. S. V. Satish
Boobalan, G.
Jayakanth, K.
author_sort Kavitha, K.
collection PubMed
description AIM: The objective of the study was to assess the effect of combination treatment of insulin, pioglitazone and synbiotic on streptozotocin (STZ)-induced diabetic rats. MATERIALS AND METHODS: Diabetes mellitus was induced chemically by intraperitoneal administration of STZ (40 mg/kg b.wt) to male Sprague-Dawley rats. The rats were divided randomly into six groups of six rats in each. Group 1 was maintained as a normal control. Group 2 was maintained as diabetic control; Group 3 was treated with insulin; Group 4 with insulin + synbiotic; Group 5 with insulin + pioglitazone; and Group 6 with insulin + synbiotic + pioglitazone. All the animals were treated for 60 days. RESULTS: Body weights, and concentration of reduced glutathione (GSH), and high-density lipoproteins cholesterol were significantly (p<0.05) reduced, whereas the concentration of blood glucose, total cholesterol, triglycerides, protein carbonyls and thiobarbituric acid reacting substances, and the activity of GSH peroxidase were significantly (p<0.05) elevated in Group 2 at the end of 8(th) week as compared to Group 1. The treatment Groups 3, 4, 5 and 6 revealed improvement in all the parameters, and the highest improvement was observed in combination Group 6. CONCLUSION: From this study, it is concluded that combination of insulin, pioglitazone and synbiotic is useful in treating diabetes.
format Online
Article
Text
id pubmed-4819359
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Veterinary World
record_format MEDLINE/PubMed
spelling pubmed-48193592016-04-05 Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats Kavitha, K. Reddy, A. Gopala Reddy, K. Kondal Kumar, C. S. V. Satish Boobalan, G. Jayakanth, K. Vet World Research Article AIM: The objective of the study was to assess the effect of combination treatment of insulin, pioglitazone and synbiotic on streptozotocin (STZ)-induced diabetic rats. MATERIALS AND METHODS: Diabetes mellitus was induced chemically by intraperitoneal administration of STZ (40 mg/kg b.wt) to male Sprague-Dawley rats. The rats were divided randomly into six groups of six rats in each. Group 1 was maintained as a normal control. Group 2 was maintained as diabetic control; Group 3 was treated with insulin; Group 4 with insulin + synbiotic; Group 5 with insulin + pioglitazone; and Group 6 with insulin + synbiotic + pioglitazone. All the animals were treated for 60 days. RESULTS: Body weights, and concentration of reduced glutathione (GSH), and high-density lipoproteins cholesterol were significantly (p<0.05) reduced, whereas the concentration of blood glucose, total cholesterol, triglycerides, protein carbonyls and thiobarbituric acid reacting substances, and the activity of GSH peroxidase were significantly (p<0.05) elevated in Group 2 at the end of 8(th) week as compared to Group 1. The treatment Groups 3, 4, 5 and 6 revealed improvement in all the parameters, and the highest improvement was observed in combination Group 6. CONCLUSION: From this study, it is concluded that combination of insulin, pioglitazone and synbiotic is useful in treating diabetes. Veterinary World 2016-02 2016-02-03 /pmc/articles/PMC4819359/ /pubmed/27051195 http://dx.doi.org/10.14202/vetworld.2016.118-122 Text en Copyright: © Kavitha, et al. http://creativecommons.org/licenses/by/4.0 Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kavitha, K.
Reddy, A. Gopala
Reddy, K. Kondal
Kumar, C. S. V. Satish
Boobalan, G.
Jayakanth, K.
Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats
title Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats
title_full Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats
title_fullStr Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats
title_full_unstemmed Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats
title_short Hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats
title_sort hypoglycemic, hypolipidemic and antioxidant effects of pioglitazone, insulin and synbiotic in diabetic rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819359/
https://www.ncbi.nlm.nih.gov/pubmed/27051195
http://dx.doi.org/10.14202/vetworld.2016.118-122
work_keys_str_mv AT kavithak hypoglycemichypolipidemicandantioxidanteffectsofpioglitazoneinsulinandsynbioticindiabeticrats
AT reddyagopala hypoglycemichypolipidemicandantioxidanteffectsofpioglitazoneinsulinandsynbioticindiabeticrats
AT reddykkondal hypoglycemichypolipidemicandantioxidanteffectsofpioglitazoneinsulinandsynbioticindiabeticrats
AT kumarcsvsatish hypoglycemichypolipidemicandantioxidanteffectsofpioglitazoneinsulinandsynbioticindiabeticrats
AT boobalang hypoglycemichypolipidemicandantioxidanteffectsofpioglitazoneinsulinandsynbioticindiabeticrats
AT jayakanthk hypoglycemichypolipidemicandantioxidanteffectsofpioglitazoneinsulinandsynbioticindiabeticrats